Lixisenatide as a treatment for early Parkinson’s disease progression
1. In this randomized controlled trial, lixisenatide reduced motor disability progression in Parkinson’s patients. 2. Individuals in the lixisenatide group ...
Tag: Lixisenatide
Lixisenatide ineffective in reducing cardiovascular events in diabetics: The ELIXA study
1. Treatment with lixisenatide in type 2 diabetic (DM2) patients was shown to result in rates of coronary events similar ...